Liraglutide with diet before weight-loss surgery
Part of Hormones & metabolism clinical trials.
This study tests whether taking a medication called liraglutide (Saxenda) before weight-loss surgery, along with a special diet, helps people lose more weight than just the diet alone. It may help you prepare for surgery and improve your results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to have weight-loss surgery and have a BMI over 35.
- You have public health insurance through the Österreichische Gesundheitskasse.
- You are willing to follow a diet program before surgery.
- You agree to have blood tests and body weight scans.
- You have not had prior weight-loss surgery.
- You are at least 18 years old and do not have any serious psychiatric conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing two weight-loss medications: liraglutide alone or combined with orlistat. It is for adults who are overweight or obese and have certain related health conditions like high blood pressure or type 2 diabetes. The goal is to see which treatment works better for long-term weight loss.
This trial tests whether bariatric surgery or the drug liraglutide helps people with obesity lose weight and keep it off by looking at how it affects your thinking and behavior. It might help you understand which treatment works best for long-term success.
This trial tests whether adding a GLP-1 medication (a type of diabetes and weight-loss drug) after weight-loss surgery helps patients with obesity and related health conditions like diabetes. Researchers want to see if combining surgery with this medicine works better than surgery alone.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This trial is for people who had metabolic surgery 6 months ago and still have a BMI of 28 or higher. It tests whether an anti-obesity medication can help with further weight loss after surgery.
This trial tests if semaglutide (a weekly injection) helps people who lost less weight than expected after gastric bypass or sleeve surgery. It's for patients who had a high BMI before surgery and are in a special support program.
Hear when a new Obesity, Adolescent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.